Christopher Hite's most recent trade in Royalty Pharma plc - Ordinary Shares - Class A was a trade of 1,238,789 Class E Ordinary Shares done . Disclosure was reported to the exchange on May 16, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Royalty Pharma plc - Ordin... | Christopher Hite | EVP & Vice Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2025 | 1,238,789 | 1,238,789 | - | - | Class E Ordinary Shares | |
| Royalty Pharma plc - Ordin... | Christopher Hite | EVP & Vice Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2025 | 48,646 | 648,646 | - | 0 | Class A Ordinary Shares | |
| Royalty Pharma plc - Ordin... | Christopher Hite | EVP & Vice Chairman | 14 Feb 2025 | 300,000 | 600,000 | - | 0 | Class A Ordinary Shares | ||
| Royalty Pharma plc - Ordin... | Christopher Hite | EVP & Vice Chairman | 14 Feb 2025 | 30,000 | 86,641 | - | - | LP interests in RPI US Partners 2019, LP | ||
| Royalty Pharma plc - Ordin... | Christopher Hite | EVP & Vice Chairman | 13 May 2024 | 300,000 | 370,000 | - | 0 | Class A Ordinary Shares | ||
| Royalty Pharma plc - Ordin... | Christopher Hite | EVP & Vice Chairman | 13 May 2024 | 30,000 | 541 | - | - | LP interests in RPI US Partners 2019, LP | ||
| Royalty Pharma plc - Ordin... | Christopher Hite | EVP & Vice Chairman | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 23 Mar 2021 | 31,959 | 30,541 | - | - | LP interests in RPI US Partners 2019, LP |